Honokiol as an α-glucosidase inhibitor

Hua Zhu,Xin Zhong
DOI: https://doi.org/10.3389/fphar.2024.1425832
IF: 5.6
2024-06-20
Frontiers in Pharmacology
Abstract:Honokiol, a naturally occurring compound from Magnolia obovata Thunb ., has many biological activities, but its anti-α-glucosidase activity is still unclear. Therefore, we determined its inhibitory effects against α-glucosidase. Activity assays showed that honokiol was a reversible mixed-type inhibitor of α-glucosidase, and its IC 50 value was 317.11 ± 12.86 μM. Fluorescence results indicated that the binding of honokiol to α-glucosidase caused a reduction in α-glucosidase activity. 3D fluorescence and CD spectra results indicated that the binding of honokiol to α-glucosidase caused conformational change in α-glucosidase. Docking simulated the detailed interactions between honokiol and α-glucosidase, including hydrogen and hydrophobic bonds. All findings showed that honokiol could be used as a natural inhibitor to develop α-glucosidase agents.
pharmacology & pharmacy
What problem does this paper attempt to address?